The mitochondrial translocator protein (TSPO) upregulates antioxidant genes and PD-L1 expression via the p62/KEAP1/Nrf2 pathway, offering resistance to ferroptosis and suppressing anti-tumor immunity in HCC [54]. This evidence concerns the gene CD274 and hepatocellular carcinoma.